Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now lists 136 investigational sites across various countries and updates trial durations/outcome timeframes (e.g., weeks-based horizons), reflecting the current scope of the DREAMM-3 study.
    Difference
    4%
    Check dated 2026-07-07T06:22:31.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's related topics were expanded to include Multiple myeloma and MedlinePlus Genetics, and the site revision was updated from v3.6.0 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-06-30T01:24:49.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now indicates the study is no longer recruiting participants, clarifying current enrollment status. Additionally, new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the Intervention/Treatment label was reformatted.
    Difference
    0.3%
    Check dated 2026-06-15T19:21:27.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new page revision tag Revision: v3.5.5 was added, and the previous Revision: v3.5.4 was removed, indicating an update to the page's versioning.
    Difference
    0.0%
    Check dated 2026-06-08T16:40:54.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added related topics entries for Multiple myeloma and MedlinePlus Genetics to the page, linking the study to disease-specific and genetics resources. This situates the page within broader educational materials without changing the primary study details.
    Difference
    0.1%
    Check dated 2026-06-01T13:23:20.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Deleted 'Multiple myeloma' and the 'MedlinePlus Genetics' entry from the related topics section, reducing the visible navigation links to those topics.
    Difference
    0.1%
    Check dated 2026-05-25T08:18:08.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.